Successful
Journal
The European respiratory journal
ISSN: 1399-3003
Titre abrégé: Eur Respir J
Pays: England
ID NLM: 8803460
Informations de publication
Date de publication:
10 2020
10 2020
Historique:
received:
12
07
2019
accepted:
21
05
2020
pubmed:
31
5
2020
medline:
22
6
2021
entrez:
31
5
2020
Statut:
epublish
Résumé
Long-term survival after lung transplantation (LTx) is hampered by development of chronic lung allograft dysfunction (CLAD).
Identifiants
pubmed: 32471935
pii: 13993003.01720-2020
doi: 10.1183/13993003.01720-2020
pii:
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Commentaires et corrections
Type : CommentIn
Type : CommentIn
Type : CommentIn
Informations de copyright
Copyright ©ERS 2020.
Déclaration de conflit d'intérêts
Conflict of interest: B. De Muynck has nothing to disclose. Conflict of interest: A. Van Herck has nothing to disclose. Conflict of interest: A. Sacreas has nothing to disclose. Conflict of interest: T. Heigl has nothing to disclose. Conflict of interest: J. Kaes has nothing to disclose. Conflict of interest: A. Vanstapel has nothing to disclose. Conflict of interest: S.E. Verleden reports grants from FWO (12G8715N) and KULeuven (C24/18/073), outside the submitted work. Conflict of interest: A.P. Neyrinck reports grants from KULeuven (C24/18/073), outside the submitted work. Conflict of interest: L.J. Ceulemans has nothing to disclose. Conflict of interest: D.E. Van Raemdonck has nothing to disclose. Conflict of interest: K. Lagrou reports personal fees for consultancy from Pfizer, Abbott, MSD and SMB Laboratoires Brussels, personal fees for travel support from Pfizer and MSD, personal fees for lectures from Gilead, MSD, Roche and Abbott, outside the submitted work. Conflict of interest: B.M. Vanaudenaerde reports grants from KULeuven, outside the submitted work. Conflict of interest: G.M. Verleden reports grants from the Broere Charitable foundation, outside the submitted work. Conflict of interest: R. Vos reports grants from FWO (12G8715N), Roche (through the Belgian Transplant Society and Sandoz, outside the submitted work.